|
Clerk of the House of Representatives Legislative Resource Center 135 Cannon Building Washington, DC 20515 http://lobbyingdisclosure.house.gov |
Secretary of the Senate Office of Public Records 232 Hart Building Washington, DC 20510 http://www.senate.gov/lobby |
LOBBYING REGISTRATION
Lobbying Disclosure Act of 1995 (Section 4)
| 1. Effective Date of Registration | 6/8/2025 |
||||
| 2. House Identification | 43856 |
Senate Identification | 401104690 |
||
REGISTRANT Organization/Lobbying Firm Self Employed Individual
| 3. Registrant | Organization | BLACK DIAMOND STRATEGIES LLC |
||||
| Address | 2121 Lohmans Crossing Road |
Address2 | Ste 504-101 |
| City | Austin |
State | TX |
Zip | 78734 |
Country | USA |
4. Principal place of business (if different than line 3)
| City |
|
State |
|
Zip |
|
Country |
|
| 5. Contact name and telephone number | International Number |
| Contact | Mr. David Satterfield |
Telephone | 7035497705 |
dsatterfield@hdafec.com |
CLIENT A Lobbying Firm is required to file a separate registration for each client. Organizations employing in-house lobbyists should check the box labeled “Self” and proceed to line 10. Self
| 7. Client name | On Demand Pharmaceuticals, Inc. |
| Address | 1550 E Gude Dr |
| City | Rockville |
State | MD |
Zip | 20850 |
Country | USA |
| City |
|
State |
|
Zip |
|
Country |
|
LOBBYISTS
10. Name of each individual who has acted or is expected to act as a lobbyist for the client identified on line 7. If any person listed in this section has served as a “covered executive branch official” or “covered legislative branch official” within twenty years of first acting as a lobbyist for the client, state the executive and/or legislative position(s) in which the person served.
| Name | Covered Official Position (if applicable) | ||
First |
Last |
Suffix |
|
| Hans | Klingler | | U.S. House Chief of Staff (2010-2015), U.S. Senate Regional Director (1995-1997) |
| | | | |
| | | | |
| | | | |
| | | | |
LOBBYING ISSUES
11. General lobbying issue areas (Select all applicable codes).
PHA |
|
|
|
|
|
|
|
|
12. Specific lobbying issues (current and anticipated)
Pharmaceutical manufacturing on demand
AFFILIATED ORGANIZATIONS
13. Is there an entity other than the client that contributes more than $5,000 to the lobbying activities of the registrant in a quarterly period and either participates in and/or in whole or in major part supervises or controls the registrant’s lobbying activities?
| No --> Go to line 14. | Yes --> Complete the rest of this section for each entity matching the criteria above, then proceed to line 14. |
| Internet Address: |
|
| Name | Address | Principal Place of Business | ||||||||
| Street | ||||||||||
|
||||||||||
|
|
|
||||||||
|
|
|||||||||
|
|
|
||||||||
|
|
|||||||||
|
|
|
||||||||
|
|
FOREIGN ENTITIES
14. Is there any foreign entity
a) holds at least 20% equitable ownership in the client or any organization identified on line 13; or
b) directly or indirectly, in whole or in major part, plans, supervises, controls, directs, finances or subsidizes activities of the client or any organization identified on line 13; or
c) is an affiliate of the client or any organization identified on line 13 and has a direct interest in the outcome of the lobbying activity?
| No --> Sign and date the registration. | Yes --> Complete the rest of this section for each entity matching the criteria above, then sign the registration. |
| Address | Ownership | |||||
| Name | Street | Principal place of business | Amount of contribution | |||
|
(city and state or country) | for lobbying activities | ||||
|
|
|||||||||||
|
|
|
|
|
% | |||||||
|
|
|||||||||||
|
|
|
|
|
% |
CONVICTIONS DISCLOSURE
15. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
| Signature | Digitally Signed By: Hans Klingler |
Date | 7/21/2025 4:20:40 PM |